Fortrea Holdings (FRA:K67) EV-to-EBIT : 560.84 (As of May. 23, 2024)

View and export this data going back to 2023. Start your Free Trial

What is Fortrea Holdings EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Fortrea Holdings's Enterprise Value is €3,643 Mil. Fortrea Holdings's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was €6 Mil. Therefore, Fortrea Holdings's EV-to-EBIT for today is 560.84.

The historical rank and industry rank for Fortrea Holdings's EV-to-EBIT or its related term are showing as below:

FRA:K67' s EV-to-EBIT Range Over the Past 10 Years
Min: 19.54 Med: 39.01 Max: 769.63
Current: 599.09

During the past 4 years, the highest EV-to-EBIT of Fortrea Holdings was 769.63. The lowest was 19.54. And the median was 39.01.

FRA:K67's EV-to-EBIT is ranked worse than
99.05% of 422 companies
in the Biotechnology industry
Industry Median: 10.345 vs FRA:K67: 599.09

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Fortrea Holdings's Enterprise Value for the quarter that ended in Mar. 2024 was €4,722 Mil. Fortrea Holdings's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was €6 Mil. Fortrea Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 0.14%.

Fortrea Holdings EV-to-EBIT Historical Data

The historical data trend for Fortrea Holdings's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fortrea Holdings EV-to-EBIT Chart

Fortrea Holdings Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

EV-to-EBIT

65.85

Fortrea Holdings Quarterly Data
	Dec20	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-EBIT	Get a 7-Day Free Trial						-	26.78	36.21	65.85	785.42

Competitive Comparison of Fortrea Holdings's EV-to-EBIT

For the Biotechnology subindustry, Fortrea Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fortrea Holdings's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Fortrea Holdings's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Fortrea Holdings's EV-to-EBIT falls into.

Fortrea Holdings EV-to-EBIT Calculation

Fortrea Holdings's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	3642.682	/	6.495
	=	560.84

Fortrea Holdings's current Enterprise Value is €3,643 Mil.
Fortrea Holdings's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €6 Mil.

Fortrea Holdings (FRA:K67) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Fortrea Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 )	=	EBIT	/	Enterprise Value (Q: Mar. 2024 )
	=	6.495	/	4721.8096
	=	0.14 %

Fortrea Holdings's Enterprise Value for the quarter that ended in Mar. 2024 was €4,722 Mil.
Fortrea Holdings's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €6 Mil.

Fortrea Holdings EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Fortrea Holdings's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Fortrea Holdings (FRA:K67) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Fortrea Holdings Inc (FRA:K67) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

FTRE:USA

Address

8 Moore Drive, Durham, NC, USA, 27709

Website

https://www.fortrea.com

Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after LabCorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Fortrea Holdings (FRA:K67) Headlines

No Headlines